Most medtech fails on adoption, not on technology.

Specialist cardiologists and electrophysiologists provide independent clinical input from the initial assessment onward, helping evaluate clinical relevance, workflow fit, unmet need, and development considerations. The physicians who evaluate a technology are drawn from a national network of practicing cardiologists and electrophysiologists with direct knowledge of clinical workflows, unmet needs, and real-world implementation considerations.

Regulatory and FDA strategy, evidence planning, and adoption pathways, so that a cleared technology reaches routine clinical use. We are also able to place a technology in front of practicing operators and generate clinical evidence quickly, which compresses the most expensive part of a company’s timeline.

Acquisition-oriented capital with physician involvement. Our work is directed at establishing genuine product-market fit, meaning evidence that a technology performs across operators and fits the delivery of care, since that is what an acquirer ultimately underwrites. We hold established relationships with the major cardiovascular strategics, and we ask from the outset who should eventually own the category and what must be demonstrated before they will act. In several cases the most valuable contribution has been repositioning: revising the indication, the setting of care, or the intended acquirer, so that the company presented to the market differs materially from the one we first met.